Procter & Gamble (PG) came out with quarterly earnings of $1.88 per share, beating the Zacks Consensus Estimate of $1.87 per share. This compares to earnings of $1.88 per share a year ago.
Procter & Gamble posted slightly higher revenue in its latest quarter as higher prices helped offset a decline in volumes.
Procter & Gamble depends on productivity from cost savings to supply-chain efficiencies to protect margins and support EPS as inflation pressures persist.
PG moves toward Q2 results, with modest sales growth expectations, but margin pressure from commodities, tariffs and competition keeps investors cautious.
Good dividend stocks provide reliable, passive income. Look for dividend companies with a strong track record of paying the dividend.
Beyond analysts' top-and-bottom-line estimates for P&G (PG), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.
Investors need to pay close attention to PG stock based on the movements in the options market lately.
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In the most recent trading session, Procter & Gamble (PG) closed at $143.46, indicating a +1.12% shift from the previous trading day.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Zacks.com users have recently been watching P&G (PG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Procter & Gamble remains a 'Hold' as shares trade slightly above intrinsic value despite a wide economic moat and solid fundamentals. Procter & Gamble's Q1/26 saw 3% revenue growth and 21% EPS growth, but management guides for low-to-mid single-digit growth ahead. Valuation multiples—20.5x earnings and 23x FCF—remain elevated relative to growth prospects, with intrinsic value estimated at $122.63.